Veterinary antibacterials—antiseptics that only act against bacteria—comprise some of the most important pharmaceutical products on the animal health market. Yet despite a difficult regulatory environment—driven by concerns over the development of antibacterial resistance in consumers of livestock products—new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets.

TABLE OF CONTENTS



1 Report Overview 5

1.1 Objectives of Report 5

1.2 Scope of Report 5

1.3 Methodology 5

1.4 Executive Summary 6



2 Animal Health Products Markets 8

2.1 Overview 8

2.2 Overview of Health Products Market 9

2.2.1 World Products Markets 9

2.2.2 U.S. Animal Health Products Market 11

2.2.3 European Animal Health Markets 12

2.2.4 Asian Animal Health Products Markets 12

2.3 Key Sector Highlights 14

2.4 Biologicals Products Category 14

2.5 Companion Animal Health Products 14

2.6 Commercially Significant Bacterial Infections in Farm Animals 16

2.7 Common Animal Diseases 16



3 Antibacterals Markets 32

3.1 Overview 32

3.2 Antibiotics Market Size 32

3.3 Global Sales of Animal Health Antibiotics by Region 33

3.3.1 U.S. Sales of Animal Health Antibiotics 33

3.3.2 European Sales of Animal Health Antibiotics 36

3.3.3 Japanese Sales of Animal Health Products 37

3.4 Key Findings 37

3.5 Animal Health Antibiotics Market Drivers 38

3.6 Sector Comments 38

3.7 Growth Promotion in Livestock 39



4 Regulatory Overview of the Veterinary Health Market 44

4.1 Regulatory Environment 44

4.2 General Overview 44

4.3 Product Marketing Authority 45

4.4 Regulation of Animal Health Products in the European Union 45

4.5 Regulation of Animal Health Products in the U.S. 47

4.5.1 USDA 47

4.5.2 FDA 48

4.5.3 EPA 48

4.6 Regulation of Animal Health Products in Japan 48

4.6.1 Japanese Regulatory Environment 48

4.6.2 Withdrawal Periods 48

4.6.3 Japanese Filing Procedures for New Animal Drug Applications 49

4.6.4 Use of Outdated Animal Studies 49

4.7 Brand-Specific Listing for Antimicrobial Antibiotic and Other Feed Additives 49

4.8 Proposed Regulation of Animal Antibiotics 49

4.9 Antibiotic Acquired Resistance and Animal Usage 50



5 Business Trends in the Industry 51

5.1 The European Animal Health Industry 51

5.2 Trends Driving Demand 51

5.3 Antibiotic Usage 51

5.4 Mergers and Acquisitions 51

5.5 New Product Launches 52

5.6 Bioterrorism and Food borne Pathogens?WHO Guidelines 53

5.7 Animal Health Additive Growth Trends 54



6 Company Profiles 55

6.1 Abbott Laboratories 55

6.2 Agricultural Research Service 55

6.3 Alpharma Inc. 56

6.4 BASF Agricultural Products and Nutrition 60

6.5 Bayer Animal Health 60

6.6 Boehringer Ingelheim Corp. 61

6.7 Elanco Animal Health 62

6.8 Fort Dodge Animal Health (Wyeth) 62

6.9 Heska Animal Health 63

6.10 Intervet International 65

6.11 IVAX Corporation 65

6.12 Merial Animal Health 65

6.13 Novartis Animal Health 67

6.14 Pfizer Animal Health 68

6.15 Roche Animal Nutrition and Health 74

6.16 Sanofi-Aventis 74

6.17 Schering-Plough Animal Health 76

6.18 Virbac S.A. 76

6.19 Wyeth (Fort Dodge Animal Health) 77





INDEX OF FIGURES



Figure 2.1: Worldwide Sales of Animal Health Products Market by Product Class, 2006 10

Figure 2.2: Worldwide Animal Health Products Market by Region, 2006 11

Figure 2.3: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006 12

Figure 2.4: Worldwide Animal Health Products Market by Species, 2006 15





INDEX OF TABLES



Table 2.1: World Market for Animal Health Products, 2004-2012 9

Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012 10

Table 2.3: Worldwide Animal Health Products Market by Region, 2006 11

Table 2.4: U.S. Animal Health Product Sales, 2004-2012 11

Table 2.5: Japanese Animal Health Market, 2000-2012 13

Table 2.6: Worldwide Animal Health Product Sales for Leading Producers, 2006 13

Table 2.7: Dog and Cat Food Manufacturers 15

Table 2.8: Commercially Significant Bacterial Infections in Pigs 16

Table 2.9: Commercially Significant Bacterial Infections in Poultry 16

Table 2.10: Commercially Significant Bacterial Infections in Cattle 16

Table 2.11: List A Diseases 17

Table 2.12: List B Diseases 17

Table 2.13: Cattle Diseases 18

Table 2.14: Sheep and Goat Diseases 18

Table 2.15: Equine Diseases 19

Table 2.16: Swine Diseases 19

Table 2.17: Avian Diseases 19

Table 2.18: Fish Diseases 20

Table 2.19: Other Veterinary Diseases 20

Table 3.1: Antimicrobials 32

Table 3.2: Worldwide Sales of Animal Health Antibiotics, 2004-2012 33

Table 3.3: U.S. Sales of Animal Health Antibiotics, 2004-2012 33

Table 3.4: U.S. Volume of Animal Health Antibiotics Used, 1999-2006 34

Table 3.5: Sales of Bayer’s Baytril, 2003-2009 34

Table 3.6: Enrofloxacin (Quinolones) 35

Table 3.7: U.S. Volume of Animal Health Antibiotics Used by Class Category, 2000-2005 36

Table 3.8: European Sales of Animal Health Antibiotics, 2004-2012 36

Table 3.9: European Veterinary Consumption of Therapeutic Antibiotics 36

Table 3.10: Japanese Sales of Animal Health Antibiotics, 2004-2012 37

Table 3.11: Animal Health Antibiotics Market Drivers 38

Table 3.12: Commercial Animal Health Antibacterials by Class Type 41

Table 3.13: Bacterial and Protozoal Threats to Poultry 42

Table 3.14: Bacterial and Protozoal Threats to Pigs 43

Table 6.2: Alpharma Loss and Discontinued Operations by Business Segment, 2004-2006 58

Table 6.3: Pfizer Animal Health Products 69

Table 6.4: Pfizer Product Patents, 2006-2012 70

Table 6.5: Key Pfizer Animal Health Products 73

Table 6.6: Pfizer Livestock Products 73

Table 6.7: Pfizer Equine Products 73

Table 6.8: Pfizer Companion Animal Products 74